Trial Profile
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sotagliflozin (Primary) ; Ethinylestradiol/norgestimate
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 01 Sep 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 14 Jul 2015 New trial record